» Articles » PMID: 22271930

Protective Role of D-amino Acid Oxidase Against Staphylococcus Aureus Infection

Overview
Journal Infect Immun
Date 2012 Jan 25
PMID 22271930
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

D-Amino acid oxidase (DAO) is a hydrogen peroxide-generating enzyme that uses a D-amino acid as a substrate. We hypothesized that DAO may protect against bacterial infection, because hydrogen peroxide is one of the most important molecules in the antibacterial defense systems in mammals. We show here that DAO suppressed the growth of Staphylococcus aureus in a manner that depended on the concentration of DAO and D-amino acid in vitro. Addition of catalase abolished the bacteriostatic activity of DAO. Although DAO plus D-Ala showed less bactericidal activity, addition of myeloperoxidase (MPO) greatly enhanced the bactericidal activity of DAO. Furthermore, DAO was able to utilize bacterial lysate, which contains D-Ala derived from peptidoglycan; this could produce hydrogen peroxide with, in the presence of myeloperoxidase, formation of hypochlorous acid. This concerted reaction of DAO and MPO led to the bactericidal action. In vivo experiments showed that DAO(-/-) (mutant) mice were more susceptible to S. aureus infection than were DAO(+/+) (wild-type) mice. These results suggest that DAO, together with myeloperoxidase, may play an important role in antibacterial systems in mammals.

Citing Articles

The Potential Mechanism of D-Amino Acids - Mitochondria Axis in the Progression of Diabetic Kidney Disease.

Thuy Linh H, Nakade Y, Wada T, Iwata Y Kidney Int Rep. 2025; 10(2):343-354.

PMID: 39990887 PMC: 11843130. DOI: 10.1016/j.ekir.2024.11.008.


Tryptophan Metabolism 'Hub' Gene Expression Associates with Increased Inflammation and Severe Disease Outcomes in COVID-19 Infection and Inflammatory Bowel Disease.

Bustamante S, Yau Y, Boys V, Chang J, Paramsothy S, Pudipeddi A Int J Mol Sci. 2022; 23(23).

PMID: 36499104 PMC: 9737535. DOI: 10.3390/ijms232314776.


The 35th Anniversary of the Discovery of EPR Effect: A New Wave of Nanomedicines for Tumor-Targeted Drug Delivery-Personal Remarks and Future Prospects.

Maeda H J Pers Med. 2021; 11(3).

PMID: 33810037 PMC: 8004895. DOI: 10.3390/jpm11030229.


Antimicrobial D-amino acid oxidase-derived peptides specify gut microbiota.

Murtas G, Sacchi S, Tedeschi G, Maffioli E, Notomista E, Cafaro V Cell Mol Life Sci. 2021; 78(7):3607-3620.

PMID: 33484270 PMC: 8038955. DOI: 10.1007/s00018-020-03755-w.


Innate immune gene expression in Acropora palmata is consistent despite variance in yearly disease events.

Young B, Serrano X, Rosales S, Miller M, Williams D, Traylor-Knowles N PLoS One. 2020; 15(10):e0228514.

PMID: 33091033 PMC: 7580945. DOI: 10.1371/journal.pone.0228514.


References
1.
Kanafani H, Martin S . Catalase and superoxide dismutase activities in virulent and nonvirulent Staphylococcus aureus isolates. J Clin Microbiol. 1985; 21(4):607-10. PMC: 271729. DOI: 10.1128/jcm.21.4.607-610.1985. View

2.
Briggs R, Karnovsky M, Karnovsky M . Hydrogen peroxide production in chronic granulomatous disease. A cytochemical study of reduced pyridine nucleotide oxidases. J Clin Invest. 1977; 59(6):1088-98. PMC: 372321. DOI: 10.1172/JCI108732. View

3.
Fang J, Sawa T, Akaike T, Maeda H . Tumor-targeted delivery of polyethylene glycol-conjugated D-amino acid oxidase for antitumor therapy via enzymatic generation of hydrogen peroxide. Cancer Res. 2002; 62(11):3138-43. View

4.
Baehner R, Nathan D, Karnovsky M . The metabolic and bactericidal defect in chronic granulomatous disease. Vox Sang. 1969; 17(1):35-6. View

5.
Robinson J, Briggs R, Karnovsky M . Localization of D-amino acid oxidase on the cell surface of human polymorphonuclear leukocytes. J Cell Biol. 1978; 77(1):59-71. PMC: 2110022. DOI: 10.1083/jcb.77.1.59. View